Bloomberg: JTI's 2023 Cigarette Shipment Volume Rises, the Only in 3 Tobacco Giants

JTI by 2FIRSTS

Feb.19.2024

Bloomberg: JTI's 2023 Cigarette Shipment Volume Rises, the Only in 3 Tobacco Giants

The difference in sales highlights JTI's differences in strategy. As PMI and BAT shift more research and marketing resources towards alternative products including e-cigarettes, heated tobacco, and nicotine pouches, JTI is more inclined to try to increase market share and sales in traditional cigarettes.

Japan Tobacco International (JTI), the parent company headquartered in Geneva, announced during the release of its annual financial report that the total sales volume of JTI's cigarette brands Winston and Camel increased by 2.3% in 2023.

For comparison, Philip Morris International Inc. transported approximately 613 billion cigarettes in 2023, a decrease of 1.3% from the previous year. British American Tobacco Plc manufactured and transported approximately 555 billion cigarettes last year, a decrease of 8.2% from 2022.

Philip Morris International (PMI) has reported that about one-third of its revenue now comes from smoke-free alternatives, and it plans to increase this proportion to half by 2025. In its recent annual performance report, PMI announced that net revenue from its IQOS heated tobacco product surpassed its flagship brand, Marlboro, in the fourth quarter.

British American Tobacco (BAT) revealed in its annual performance report that its alternative products, including Vuse e-cigarettes and Velo nicotine pouches, are now profitable earlier than previously expected.

Also Read:

[1] JT Group Reports Record Profits in 2023FY: Ploom Occupying More than 10% of Japan's HNB Market

[2] BAT's 2023 Financial Report: New Categories Drive Revenue Growth

#JTI

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

Verkhovna Rada is reviewing six bills to regulate new nicotine products such as pouches and vapes. The main bill, No.14110, proposes a total ban on production, import, and sale, while alternative proposals seek regulation instead of prohibition.

Nov.10 by 2FIRSTS.ai

UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales

According to The Guardian, health experts in the UK are warning about the potential health effects of high-dose nicotine pouches as their sales continue to rise. Recent studies show teenagers reporting nicotine rushes, sickness and fainting, while researchers say packaging and marketing increasingly appeal to younger age groups. Although viewed as less harmful than cigarettes, experts remain concerned about their use among non-smokers, especially adolescents.

Nov.13 by 2FIRSTS.ai

Report: Smoking Rates Remain Unchanged Despite Kazakhstan’s Vape Ban

According to Exclusive.KZ, Kazakhstan’s Strategy Public Foundation released a study finding that strict tobacco and vape bans have not reduced smoking rates, which remain at 18–20%. The report calls for harm reduction approaches based on international best practices.

Nov.06 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.